UroGen Pharma Ltd. Ordinary Shares (URGN) News
Latest headlines that mention URGN, newest first · each headline opens the original publisher
- Last price
- $34.04
- Day change
- -1.30%
- Next earnings
- 2026-11-05
URGN headlines
latest coverageZUSDURI revenue hit $50.4M, growing 73% QoQ as adoption expands into community practices.
Mark Schoenberg's final disposition under a pre-established Rule 10b5-1 plan follows 191% annual returns, leaving him with 119,763 shares worth $4.82 million.
Focused on innovative cancer therapies, this biotech saw a notable insider sale amid a year of strong share price gains.
Focused on urinary tract cancer therapies, this biotech saw a notable insider sale amid a year of strong share price gains.
URGN news alerts
Get an alert by email or push when a new headline mentions URGN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.